• Home

  • About

    • Our Team

  • Partners

  • Solutions

  • News

  • Contact

  • More

    Use tab to navigate through the menu items.

    info@navaux.com
    501-353-0014

    • Facebook
    • LinkedIn
    navaux-logo copy.png

    News

    Hepsin regulates TGFβ signaling via fibronectin proteolysis

    Hepsin regulates TGFβ signaling via fibronectin proteolysis

    0

    ARKANSAS SCIENTISTS DEVELOP BLOOD TEST TO DETECT EARLY STAGE CANCER

    0
    NAVAUX PRESENTS PRE-CLINICAL AND CLINICAL CIRCULATING HEPSIN DATA AT THE 2020 AACR ANNUAL MEETING

    NAVAUX PRESENTS PRE-CLINICAL AND CLINICAL CIRCULATING HEPSIN DATA AT THE 2020 AACR ANNUAL MEETING

    0
    HEPSIN IN THE DIAGNOSIS OF PROSTATE CANCER

    HEPSIN IN THE DIAGNOSIS OF PROSTATE CANCER

    BAPTIST HEALTH AND NAVAUX, INC. OFFER EARLY STAGE CANCER DETECTING BLOOD TEST

    BAPTIST HEALTH AND NAVAUX, INC. OFFER EARLY STAGE CANCER DETECTING BLOOD TEST

    0

    Stay Informed

    Sign up to receive the latest news on clinical
    trials, publications, investor news and more.

    Thanks for submitting!

    2021 © Navaux, Inc.